Atovaquone-proguanil use in early pregnancy and the risk of birth defects

Arch Intern Med. 2011 Feb 14;171(3):259-60. doi: 10.1001/archinternmed.2010.521.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Drug-Induced / epidemiology
  • Abnormalities, Drug-Induced / etiology*
  • Antimalarials / administration & dosage
  • Antimalarials / toxicity*
  • Atovaquone / administration & dosage
  • Atovaquone / toxicity*
  • Cohort Studies
  • Cross-Sectional Studies
  • Denmark
  • Drug Combinations
  • Drug-Related Side Effects and Adverse Reactions
  • Female
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Malaria / prevention & control*
  • Pregnancy
  • Pregnancy Complications, Parasitic / prevention & control*
  • Product Surveillance, Postmarketing / statistics & numerical data
  • Proguanil / administration & dosage
  • Proguanil / toxicity*
  • Registries / statistics & numerical data

Substances

  • Antimalarials
  • Drug Combinations
  • atovaquone, proguanil drug combination
  • Proguanil
  • Atovaquone